IgY Reduces AFB1-Induced ... - ACS Publications

Subscriber access provided by READING UNIV

Article

IgY reduces AFB1-induced cytotoxicity, cellular dysfunction, and genotoxicity in human L-02 hepatocytes and Swan 71 trophoblasts Taotao Qiu, Xing Shen, Zhen Tian, Riming Huang, Xiangmei Li, Juan Wang, Rong Wang, Yuanming Sun, Yiguo Jiang, Huidong Zhang, and Hongtao Lei J. Agric. Food Chem., Just Accepted Manuscript • DOI: 10.1021/acs.jafc.7b05385 • Publication Date (Web): 11 Jan 2018 Downloaded from http://pubs.acs.org on January 13, 2018

Just Accepted “Just Accepted” manuscripts have been peer-reviewed and accepted for publication. They are posted online prior to technical editing, formatting for publication and author proofing. The American Chemical Society provides “Just Accepted” as a free service to the research community to expedite the dissemination of scientific material as soon as possible after acceptance. “Just Accepted” manuscripts appear in full in PDF format accompanied by an HTML abstract. “Just Accepted” manuscripts have been fully peer reviewed, but should not be considered the official version of record. They are accessible to all readers and citable by the Digital Object Identifier (DOI®). “Just Accepted” is an optional service offered to authors. Therefore, the “Just Accepted” Web site may not include all articles that will be published in the journal. After a manuscript is technically edited and formatted, it will be removed from the “Just Accepted” Web site and published as an ASAP article. Note that technical editing may introduce minor changes to the manuscript text and/or graphics which could affect content, and all legal disclaimers and ethical guidelines that apply to the journal pertain. ACS cannot be held responsible for errors or consequences arising from the use of information contained in these “Just Accepted” manuscripts.

Journal of Agricultural and Food Chemistry is published by the American Chemical Society. 1155 Sixteenth Street N.W., Washington, DC 20036 Published by American Chemical Society. Copyright © American Chemical Society. However, no copyright claim is made to original U.S. Government works, or works produced by employees of any Commonwealth realm Crown government in the course of their duties.

Page 1 of 36

Journal of Agricultural and Food Chemistry

1

IgY reduces AFB1-induced cytotoxicity, cellular dysfunction, and

2

genotoxicity in human L-02 hepatocytes and Swan 71 trophoblasts

3 4

Taotao Qiu†, §, Xing Shen†, Zhen Tian§, Riming Huang†, Xiangmei Li†, Juan Wang†,

5

Rong Wang§, Yuanming Sun†, Yiguo Jiang⊥, Hongtao Lei*, † and Huidong Zhang*, §

6

†

7

University, Guangzhou, 510642, China.

8

§

9

University, No.17 People's South Road, Chengdu, 610041, China.

10

Guangdong Provincial Key Laboratory of Food Quality and Safety, South China Agricultural

Public Health Laboratory Sciences and Toxicology, West China School of Public Health, Sichuan

⊥

Institute for Chemical Carcinogenesis, Guangzhou Medical University, Xinzao, Panyu District,

11

Guangzhou, China.

12

*

13

Phone: +862085283925. Fax: +862085280270

E-mails: [email protected] (H.D. Zhang); [email protected] (H.T. Lei).

ACS Paragon Plus Environment


14

Abstract:

15

Aflatoxin B1 (AFB1) causes hepatotoxic, genotoxic, and immunotoxic effects in

16

a variety of species. Although various neutralizing agents of AFB1 toxicity have been

17

studied, the egg yolk immunoglobulins (IgY) detoxification of small molecular toxins

18

and the mechanisms underlying such effects have not yet been reported. In this

19

investigation, anti-AFB1 IgY against AFB1 was successfully raised, and a competitive

20

indirect enzyme-linked immunosorbent assay was established with a sensitive

21

half-maximal inhibitory concentration (IC50, 2.4 ng/mL) and dynamic working range

22

(0.13–43.0 ng/mL). The anti-AFB1 IgY obtained reduced AFB1-induced cytotoxicity,

23

cellular dysfunction, and genotoxicity by protecting cells against apoptotic body

24

formation and DNA strand breaks, preventing G2/M phase cell cycle arrest, reducing

25

AFB1-DNA adduct and ROS production, and maintaining cell migration and invasion

26

and the mitochondrial membrane potential. Anti-AFB1 IgY significantly inhibited the

27

AFB1-induced expression of proteins related to antioxidative, pro-apoptotic, and

28

anti-apoptotic processes in a strong dose-dependent manner. These experiments

29

demonstrated that the anti-AFB1 IgY-bound AFB1 could not enter cells. This is the

30

first time that IgY has been found to reduce the effects of small molecular toxins,

31

which will be beneficial for the development of antibodies as detoxication agents.

32

Keywords: IgY, aflatoxin B1, detoxification, cytotoxicity, cellular dysfunction,

33

genotoxicity

2


Page 2 of 36

Page 3 of 36


34 35

INTRODUCTION Aflatoxins, the secondary metabolites produced by Aspergillus flavus and

36

Aspergillus parasiticus, are widely distributed in various food products and

37

simultaneously harm multiple human organs by producing a cascade of responses in

38

the affected individual.1 Among these aflatoxins, aflatoxin B1 (AFB1) is the most

39

hepatotoxic, genotoxic and immunotoxic to humans and animals.2 AFB1 is classified

40

as a Group 1 human carcinogen and has no recognized safe dose by the International

41

Agency for Research on Cancer.3 In cells, AFB1 is metabolized to AFB1

42

exo-8,9-epoxide (exo-AFBO),4 which binds to nuclear DNA and thus forms DNA

43

adducts5 that can ultimately lead to mitochondrial swelling, reduce mitochondrial

44

activity and ATP content, and induce cellular senescence and catastrophic mutation or

45

apoptosis.6 It is possible that cellular dysfunction may be due to AFB1-induced

46

alterations of cellular macromolecules.7 The toxic effect of AFB1 may also be

47

attributed to its enhancement of the reactive oxygen species (ROS) level in living

48

cells, which may attack lipids, proteins, and nucleic acids.8 Although many methods,

49

including physical, chemical, and biological treatments, have been used to degrade

50

AFB1 to improve food safety,9,10 most of these processes lead to the formation of toxic

51

residues or derivatives and a reduction in the food’s nutritional values and

52

organoleptic qualities.11

53

Egg yolk immunoglobulins (IgY), an antibody generated from chickens, is

54

composed of two light chains and two heavy chains, like mammalian counterpart

55

IgG.12 However, in contrast, IgY can neither activate the mammalian complement 3



56

system nor interact with human Fc receptors and mammalian rheumatoid factors.13

57

Additionally, chickens can produce a strong immune response against mammalian

58

antigens owing to the phylogenetic distance between mammals and birds.14 Because

59

of these advantages, IgY has been used for the treatment of various gastroenteric

60

infectious diseases,15 and against macromolecular protein toxins, such as Shiga

61

toxin,16 ricin toxin,17 botulinum toxins,18 and viper venom.19 However, the IgY

62

detoxification of small molecular toxins and the mechanism behind this effect have

63

not yet been reported.

64

In this study, AFB1 was conjugated to bovine serum albumin (BSA), in the

65

presence of excess glycolic acid (GA) as a spacer, for use as an immunizing antigen

66

(AFB1-GA-BSA) to raise IgY antibodies against in chicken. After evaluation of the

67

sensitivity and specificity of the IgY obtained, its detoxification ability was

68

investigated. This work represents the first time that an IgY has been found to be

69

capable of inhibiting AFB1-induced cytotoxicity, cellular dysfunction, and

70

genotoxicity in two typical human cell lines: L-02 hepatocytes and Swan 71

71

trophoblasts.

72 73

MATERIALS AND METHODS

74

Chemicals and Reagents

75

Aflatoxin B1 was purchased from J&K Scientific (Beijing, China). Bovine serum

76

albumin (BSA), ovalbumin (OVA), Freund’s incomplete adjuvant (FIA), Freund’s

77

complete adjuvant (FCA), dimethyl sulfoxide (DMSO), trifluoroacetic acid (TFA), 4


Page 4 of 36

Page 5 of 36


78

1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride (EDC),

79

N-hydroxysuccinimide (NHS), N,N-dimethylformamide (DMF),

80

3,3′,5,5′-tetramethylbenzidine (TMB), and horseradish peroxidase (HRP)-conjugated

81

goat anti-rabbit IgG secondary antibody were purchased from Sigma-Aldrich (St.

82

Louis, MO, USA). Anti- Zearalenone (ZEN) IgY was prepared at Guangdong

83

Provincial Key Laboratory of Food Quality and Safety (Guangzhou, China).

84

Antibodies against for superoxide dismutase 1 (SOD1), catalase (CAT), apoptosis

85

regulator (BCL2), survivin, caspase-3 and BCL2 associated X, apoptosis regulator

86

(BAX) were purchased from Bioworld Technology, Inc. (St. Louis Park, MN, USA).

87

All ingredients for the culture medium were purchased from HyClone (Logan, UT,

88

USA). The apoptosis detection kit, 2′,7′-dichlorofluorescein diacetate, JC-1 monomers,

89

cell cycle analysis kit, and Hoechst 33342 stain were purchased from Beyotime

90

(Shanghai, China). The AFB1-DNA ELISA kit was purchased from Sinogeneclon Co.,

91

Ltd. (Hangzhou, China). All other solvents and chemicals used were of analytical

92

grade.

93

Antibody Production

94

Antigens Preparation. To prepare the artificial antigen, a novel derivatization

95

method was used to modify the hapten of AFB1, by coupling it with a carrier protein

96

via the active ester synthesis method.20 In briefly, 1 g of GA (C2H4O3) was first

97

dissolved in 5 mL of TFA to produce solution A, whereas 12 mg of AFB1 was

98

dissolved in 4 mL of acetonitrile (C2H3N) to obtain solution B. Then, solution B was

99

added dropwise to solution A. The conjugation mixture was further stirred at room 5



100

temperature (RT) for 20 min and then separated by liquid chromatography to obtain

101

AFB1-GA. Then, 3 mg of AFB1-GA, 2 mg of NHS, and 3 mg of EDC were

102

sequentially dissolved in 100 µL of DMF. After mixing at RT overnight, the activated

103

hapten solution was added dropwise to 1 mL of a stirred solution of 9.4 mg of BSA.

104

Finally, the AFB1-GA-BSA solution was stored at –20 °C for use as the immunogen.

105

Determination of the efficiency of AFB1-GA conjugation to the carrier molecule was

106

carried out by UV spectroscopy. AFB1-GA-OVA was also prepared by the active ester

107

synthesis method for use as the coating antigen.

108

IgY Generation. Five 150-day-old chickens were immunized with 400 µg of

109

AFB1-GA-BSA in phosphate-buffered saline (PBS, pH 7.4) with an equal volume of

110

FCA, at four different sites of the pectoral muscle. Four booster injections of the same

111

amount of immunogen emulsified with FIA were administered at intervals of 3 weeks

112

after the initial injection. The eggs were harvested after the initial immunization and

113

stored at 4 °C before the extraction of the antibodies. The anti-AFB1 IgY (hereafter

114

abbreviated as IgY) was purified by the ammonium sulfate precipitation method

115

under acidic conditions.21 The IgY purity was identified by SDS-PAGE and quantified

116

with ImageJ software.

117

Competitive Indirect ELISA

118

The competitive indirect enzyme-linked immunosorbent assay (CI-ELISA) was

119

performed according to an ELISA protocol described previously.22 The 96-well plates

120

were coated with AFB1- GA-OVA (100 µL/well), incubated overnight at 37 °C, and

121

then washed twice with PBST solution containing 0.5% Tween-20 in PBS. The plates 6


Page 6 of 36

Page 7 of 36


122

were then blocked with blocking buffer at 37 °C for 3 h and dried at 37 °C for 1 h. For

123

the negative control wells of the pre-coated plates, IgY dilutions (50 µL/well) and

124

PBS (50 µL/well) were added. For the experimental wells, PBS was replaced with 50

125

µL of AFB1 standard. The plates were incubated at 37 °C for 40 min and then washed

126

five times with PBST. After that, 100 µL of HRP-conjugated goat anti-chicken IgY

127

(1:5000 in PBST) was added to each well and the plates were incubated at 37 °C for

128

30 min. TMB solution (100 µL/well) was then added and the plates were incubated

129

for 10 min. Finally, the reaction was stopped by the addition of 50 µL of 2 M H2SO4.

130

The absorbance of the reaction solution at 450 nm (A450) was recorded. The

131

four-parameter logistic function, plotted by Origin 8.5 (Origin Lab Corp.,

132

Northampton, MA, USA), was fitted to establish the calibration curves. The IC50

133

value was defined as the inhibitory concentration at 50% binding. The inhibition rate

134

(I) was calculated using Eq. (1):

135

I = [(A0-A)/A0] × 100%

(1)

136

Where A0 and A represented the absorbance values of the negative well and AFB1

137

standard well, respectively.

138

Cell Viability

139

L-02 and Swan 71 cells were incubated with different concentrations of AFB1

140

and IgY for 12, 24, or 48 h. IgY was serially diluted in RPMI-1640 medium and each

141

dilution was then preincubated for 30 min at 37 °C with an equal volume of AFB1 to

142

obtain various IgY and AFB1 mixtures. For the toxin control, AFB1 in RPMI-1640

143

medium without antibody was prepared. The IgY and AFB1 mixtures were added to 7



144

respective L-02 cells monolayers (100 µL/well) and incubated for 48 h at 37 °C under

145

5% CO2; anti-ZEN IgY and BSA were used as the negative control. IgY and AFB1

146

mixtures and AFB1 alone were also added to Swan 71 cells monolayers, respectively.

147

The cell viability was assessed by

148

3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. The A450

149

value of the cells was determined using a microplate reader (Thermo Fisher Scientific,

150

Waltham, MA, USA).

151

Cell Cycle and Apoptosis

152

L-02 cells were seeded in 6-well plates at 2 × 105 cells/well and divided into six

153

groups according to varying AFB1 and IgY contents (i.e., 100 µM AFB1 alone, 0.5

154

µM IgY alone, 100 µM AFB1 + 0.5 µM IgY, 100 µM AFB1 + 0.25 µM IgY, 100 µM

155

AFB1 + 0.125 µM IgY, and 0.1% DMSO as a control). The IgY and AFB1 mixtures

156

were added accordingly to the wells and incubated for 48 h. The cell cycle and

157

apoptosis analyses were conducted using cell cycle and apoptosis detection kits

158

according to the manufacturer’s instructions. The data were analyzed using FlowJo

159

software (TreeStar, San Carlos, CA, USA).

160

Cell Migration and Invasion

161

Swan 71 cells were exposed to IgY and AFB1 mixtures for 48 h. The effect of the

162

IgY and AFB1 mixtures on the migration and invasion of the cells was then assessed

163

by trans-well assay.23 The cells were imaged under a BX51 fluorescence microscope

164

(Olympus, Tokyo, Japan).

165

ROS Production 8


Page 8 of 36

Page 9 of 36


166

Cellular ROS production was measured using a ROS assay kit according to the

167

manufacturer’s instructions. After treatment with the IgY and AFB1 mixtures as

168

described above, the L-02 cells were collected and incubated with 10 µM

169

2′,7′-dichlorofluorescein diacetate for 30 min at 37 °C. The 2′,7′-dichlorofluorescein

170

in the cells was detected with a FC500 flow cytometer (Beckman Coulter Inc.,

171

Minneapolis, MN, USA). ROS production was expressed as a fold change of the

172

fluorescence intensity of the treated samples relative to the appropriate controls (fold

173

increase over control).

174

Mitochondrial Membrane Potential

175

The MMP was monitored by determining the relative amounts of emissions

176

signal from mitochondrial JC-1 monomers and aggregates. Mitochondrial

177

depolarization was indicated by the increase of the green/red fluorescence intensity

178

ratio. Cells were exposed to the IgY and AFB1 mixtures, followed by incubation with

179

JC-1 staining solution (5 µg/mL) at 37 °C for 20 min, and were then washed twice

180

with JC-1 staining buffer. All samples were observed by BX51 fluorescence

181

microscopy (Olympus, Tokyo, Japan) to confirm the JC-1labeling patterns.

182

Nuclear Morphology

183

Nuclear changes and apoptotic body formation were detected by Hoechst 33342

184

staining. L-02 cells were first treated with the indicated IgY and AFB1 mixtures. Then,

185

the attached cells were treated with Hoechst 33342 (1×) at 37 °C for 10 min, washed

186

twice with PBS, and shielded from light. The Hoechst-stained nuclei were observed

187

under a BX51 fluorescence microscope (Olympus, Tokyo, Japan). 9



188

Intracellular AFB1-DNA Adducts

189

After exposure to the IgY and AFB1 mixtures, L-02 cells were harvested at

190

1,000g for 5 min at RT. After the removal of most of the supernatant, the cell pellet

191

was resuspended in 10–50 µL of the residual liquid. PBS (200 µL) was then added to

192

wash the cells, followed by centrifugation at 1,000g at 4 °C for 5 min. The cell

193

amount was determined with an FC500 flow cytometer (Beckman Coulter Inc.,

194

Minneapolis, MN, USA). DNA was extracted using DNAzol reagent according to the

195

manufacturer’s protocol. The AFB1-DNA adduct content was quantified with an

196

AFB1-DNA ELISA kit. The AFB1-DNA content per million cells was measured with a

197

microplate reader (Thermo Fisher Scientific, Waltham, MA, USA).

198

Western Blotting Analysis

199

L-02 cells were treated with the IgY and AFB1 mixtures and the total proteins

200

were then determined by BCA method. Equal amounts of the cellular proteins were

201

separated on a 10–12% SDS-PAGE gel and the bands were then transferred onto an

202

equilibrated polyvinylidene difluoride membrane (Amersham Biosciences,

203

Buckinghamshire, UK). After blocking with 5% skimmed milk in TBST (20 mM

204

Tris-HCl, 1500 mM NaCl, and 0.1% Tween 20) at RT for 1 h, the membrane was

205

incubated overnight with primary antibodies in blocking solution at 4 °C. The primary

206

antibodies were rabbit monoclonal anti-SOD1, anti-CAT, anti-BCL2, anti-survivin,

207

anti-caspase-3, anti-BAX and anti-β-actin. The membrane was washed three times in

208

TBST for 15 min and then incubated with the secondary antibody in blocking solution

209

at RT for 1 h. The proteins were detected by an enhanced chemiluminescence 10


Page 10 of 36

Page 11 of 36


210

(Amersham Corporation, Arlington Heights, IL, USA), visualized with an LAS-3000

211

bioimaging analyzer (Fuji Film, Tokyo, Japan), and analyzed with ImageJ software.

212

Statistical Analysis

213

The experiments were repeated at least three times. Relative values were

214

standardized by setting the control values to 1.0, and all individual experimental

215

values were calculated as folds changes relative to the control values. The data from

216

different treatments were subjected to one-way analysis of variance. Values of P

IgY Reduces AFB1-Induced ... - ACS Publications

Recommend Documents